Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes
NCT02060760
Acute Coronary Syndrome, Behavior
Minneapolis, Minnesota, United States
View Trial DetailsNCT Number: NCT03507309
The National Institute for Health Research (NIHR) Cardiovascular Health Informatics Collaborative is an observational, multi-centre and longitudinal study of clinical data from collaborating hospitals. A dataset of the longitudinal record for patients who presented with a suspected acute coronary syndrome, characterised by the request of a troponin test, has been developed (NHIC-Troponin Study).
This study is active but is not currently recruiting participants.
All sexes
Observational
The NHIC Cardiovascular Project in the United Kingdom was established to enable the sharing and repurposing of routinely captured clinical data for re-use in research. Data sharing for this study has been enabled by establishing a data sharing agreement between each of the collaborating hospitals. The data sharing agreement allows data to be shared between National Health Service (NHS) hospitals in accordance with an anonymisation and de-identification profile approved by each information governance department, ensuring that patient identities are protected. Ethics approval for each dataset has been obtained which detailed the further de-identification steps to ensure that research datasets are fully anonymised.
The cardiovascular theme clinical leads developed a standard target data model specification to capture the longitudinal record for patients who presented with a suspected acute coronary syndrome, characterised by the request of a troponin test (NHIC-Troponin Study). The data model was patient centric allowing for minor discrepancies between dataset areas such as missing discharges or test results returning outside of episodes of care. The model included 156 data points, grouped into demographics, cardiovascular risk factors, emergency department attendance and inpatient episodes, biochemistry, revascularisation and mortality. All patients were followed up on the NHS Spine Application, Summary Care Record until death or censoring on 1st April 2017.
This dataset comprised all patients who had a troponin measured at each of the five major academic centres between 2010 (2008 for University College Hospital) and 2017. The investigators identified a total of 257948 patient records who underwent troponin testing during the study period.
A Committee of Experts validates the protocol methodology and supervises the data management. A Steering Committee oversees study proposals including hypotheses, study design and statistical analyses including planned outcome measures.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Hospital admission to 3 years follow-up
Number of patients who died (from any cause) including in-hospital, short-term and long-term mortality
Time frame: 3 months follow-up
Acute revascularisation will be defined as having PCI or CABG in the time window between 48 hours before and 3 months after the first troponin measurement. This will account for patients who had revascularisation, in particular PCI, as an emergency prior to their first troponin blood test and to capture revascularisation, in particular CABG, performed as an outpatient following their index admission.
Imperial College London
Other
National Institute for Health Research (NIHR) Cardiovascular Health Informatics Collaborative
Acronym: NHIC-CV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02060760
Acute Coronary Syndrome, Behavior
Minneapolis, Minnesota, United States
View Trial DetailsNCT06853626
Acute Coronary Syndrome, Acute Coronary Syndromes (ACS)
Lyngseidet, Lyngen, Norway
View Trial DetailsNCT07599540
Arterial Occlusive Diseases, Arteriosclerosis
Ljubljana, Slovenia
View Trial DetailsNCT06468982
Acute Myocardial Infarction, Arterial Occlusive Diseases
Yakutiye, Erzurum, Turkey (Türkiye)
View Trial Details